Plant responsible for contamination has been closed for two months; the FDA has not yet decided whether it can reopen<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, June 11, 2021 (HealthDay News) — About 60 million doses of the Johnson & Johnson COVID-19 vaccine must be discarded due to possible contamination, the U.S. Food and Drug Administration has decided.<\/p>\n
It will allow about 10 million doses to be distributed in the United States or shipped to other countries, but with a warning, according to people familiar with the situation, The New York Times<\/em> reported.<\/p>\n More than 100 million doses of Johnson & Johnson and at least 70 million doses of AstraZeneca made at Emergent BioSolutions in Baltimore were put on hold in March after workers contaminated a batch of the Johnson & Johnson vaccine with a key ingredient used to produce the AstraZeneca vaccine.<\/p>\n The Emergent factory has been closed for two months and the FDA has not yet decided whether it can reopen, those with knowledge of the situation told The Times<\/em>.<\/p>\n